GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (STU:B9A) » Definitions » Interest and Commission Paid

BioArctic AB (STU:B9A) Interest and Commission Paid


View and export this data going back to 2020. Start your Free Trial

What is BioArctic AB Interest and Commission Paid?

Interest and Commission Paid only applicable to companies reporting Cash Flow from Operations in direct method.


BioArctic AB (STU:B9A) Business Description

Industry
Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.